Paloma Partners’s AngioDynamics ANGO Stock Holding History

Paloma Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,345	Closed	-$201K	–	1098
2022 Q1	$201K	Buy	+9,345	New	+$212K	0.01%	1393
2021 Q4	–	Sell	-8,990	Closed	-$233K	–	1870
2021 Q3	$233K	Buy	+8,990	New	+$240K	0.01%	806
2019 Q4	–	Sell	-36,345	Closed	-$670K	–	2128
2019 Q3	$670K	Buy	36,345 +15,437	+74%	+$302K	0.01%	954
2019 Q2	$412K	Buy	20,908 +3,637	+21%	+$74.1K	0.01%	1139
2019 Q1	$395K	Buy	+17,271	New	+$375K	0.01%	1187

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Paloma Partners's ANGO Position: Q2 2022 in Review

Paloma Partners sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 9,345 shares — an estimated $201K sold.

Paloma Partners first reported a position in ANGO in Q1 2019 and held it in 5 quarters. The position peaked at $670K in Q3 2019. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.

Paloma Partners reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 9,345 AngioDynamics shares in Q2 2022, an estimated $201K.
Paloma Partners first reported a position in AngioDynamics in Q1 2019 and held it in 5 quarters.
Paloma Partners's AngioDynamics position peaked at $670K in Q3 2019.
134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.